Global Information
회사소개 | 문의 | 비교리스트

세계의 유방 재건술 시장(2020-2024년)

Breast Reconstruction Market by Product and Geography - Forecast and Analysis 2020-2024

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2020년 01월 상품 코드 922994
페이지 정보 영문 132 Pages
가격
US $ 2,500 ₩ 2,954,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,545,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,727,000 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,909,000 PDF by E-mail (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 유방 재건술 시장(2020-2024년) Breast Reconstruction Market by Product and Geography - Forecast and Analysis 2020-2024
발행일 : 2020년 01월 페이지 정보 : 영문 132 Pages

세계 유방 재건술 시장은 2020-2024년간 약 9%의 연평균 복합 성장률(CAGR)로 성장하여 10억 1,000만 달러에 달할 전망입니다. 유방암 발생률 상승이 시장 성장을 촉진하고 있습니다. 또한 강력한 연구자금이 시장 성장을 뒷받침할 것으로 예측됩니다.

세계의 유방 재건술(Breast Reconstruction) 시장에 대해 조사 분석했으며, 시장 규모 및 성장률, 시장 동향, 시장 성장 촉진요인, 과제, 시장 기회, 주요 벤더 등에 대해 체계적인 정보를 제공합니다.

목차

제1장 주요 요약

제2장 조사 범위

  • 서론
  • 달러의 통화 환산율

제3장 시장 상황

  • 시장 생태계
  • 시장의 특징
  • 시장 세분화 분석
  • 밸류체인 분석

제4장 시장 규모

  • 시장 정의
  • 시장 규모(2019년)
  • 시장 규모 및 예측(2019-2024년)
  • 시장 전망

제5장 Five Forces 분석

  • 구매자의 협상력
  • 공급업체의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 현황

제6장 고객 상황

제7장 시장 세분화 : 제품별

  • 시장 세분화 : 제품별
  • 비교 : 제품별
  • 유방 임플란트 - 시장 규모 및 예측(2019-2024년)
  • 조직확장술 - 시장 규모 및 예측(2019-2024년)
  • 시장 기회 : 제품별

제8장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 - 시장 규모 및 예측(2019-2024년)
  • 유럽 - 시장 규모 및 예측(2019-2024년)
  • 아시아 - 시장 규모 및 예측(2019-2024년)
  • 기타 지역 - 시장 규모 및 예측(2019-2024년)
  • 주요 국가
  • 시장 기회

제9장 의사결정 프레임워크

제10장 성장요인과 과제

  • 시장 성장 촉진요인
  • 시장의 과제

제11장 시장 동향

  • 강력한 연구 자금
  • 계몽 캠페인 증가
  • DBT의 인기

제12장 벤더 상황

  • 개요
  • 상황 혁신
  • 경쟁 시나리오

제13장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • Allergan Plc
  • CEREPLAS
  • Establishment Labs Holdings Inc.
  • GC Aesthetics Inc.
  • Groupe SEBBIN SAS
  • Ideal Implant Inc.
  • Johnson & Johnson
  • Laboratories Arion
  • POLYTECH Health & Aesthetics GmbH
  • Sientra Inc.

제14장 부록

  • 조사 방법
  • 약어 리스트
  • 벤더의 시장 포지셔닝 정의

제15장 TECHNAVIO에 대해

LSH 20.02.06

Technavio has been monitoring the global breast reconstruction market and it is poised to grow by USD 1.01 billion during 2020-2024, progressing at a CAGR of almost 9% during the forecast period. Our reports on breast reconstruction market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by Rising incidence of breast cancer. In addition, strong research funding is anticipated to boost the growth of the breast reconstruction market as well.

Market Segmentation

Technavio's global breast reconstruction market is segmented as below:

Product

  • Breast Implants
  • Tissue Expanders

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for breast reconstruction market growth

This study identifies strong research funding as the prime reasons driving the breast reconstruction market growth during the next few years.

Prominent vendors in breast reconstruction market

We provide a detailed analysis of around 25 vendors operating in the breast reconstruction market, including some of the vendors such as Allergan Plc, CEREPLAS, Establishment Labs Holdings Inc., GC Aesthetics Inc., Groupe SEBBIN SAS, Ideal Implant Inc., Johnson & Johnson, Laboratories Arion, POLYTECH Health & Aesthetics GmbH and Sientra Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value Chain Analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: CUSTOMER LANDSCAPE

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Breast implants - Market size and forecast 2019-2024
  • Tissue expanders - Market size and forecast 2019-2024
  • Market opportunity by product

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Strong research funding
  • Increasing number of awareness campaigns
  • Growing popularity of DBT

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Allergan Plc
  • CEREPLAS
  • Establishment Labs Holdings Inc.
  • GC Aesthetics Inc.
  • Groupe SEBBIN SAS
  • Ideal Implant Inc.
  • Johnson & Johnson
  • Laboratories Arion
  • POLYTECH Health & Aesthetics GmbH
  • Sientra Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

  • Exhibit 01: Global healthcare supplies market
  • Exhibit 02: Segments of global healthcare supplies market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendors: Key offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Customer landscape
  • Exhibit 19: Product - Market share 2019-2024 (%)
  • Exhibit 20: Comparison by product
  • Exhibit 21: Breast implants - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 22: Breast implants - Year-over-year growth 2020-2024 (%)
  • Exhibit 23: Tissue expanders - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 24: Tissue expanders - Year-over-year growth 2020-2024 (%)
  • Exhibit 25: Market opportunity by product
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Estimated breast cancer rates in 2018
  • Exhibit 39: Cosmetic surgical procedures
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Organizations conducting awareness campaigns
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Allergan Plc - Vendor overview
  • Exhibit 48: Allergan Plc - Business segments
  • Exhibit 49: Allergan Plc - Organizational developments
  • Exhibit 50: Allergan Plc - Segment focus
  • Exhibit 51: Allergan Plc - Key offerings
  • Exhibit 52: CEREPLAS - Vendor overview
  • Exhibit 53: CEREPLAS - Product segments
  • Exhibit 54: CEREPLAS - Key offerings
  • Exhibit 55: Establishment Labs Holdings Inc. - Vendor overview
  • Exhibit 56: Establishment Labs Holdings Inc. - Business segments
  • Exhibit 57: Establishment Labs Holdings Inc. - Organizational developments
  • Exhibit 58: Establishment Labs Holdings Inc. - Key offerings
  • Exhibit 59: GC Aesthetics Inc. - Vendor overview
  • Exhibit 60: GC Aesthetics Inc. - Product segments
  • Exhibit 61: GC Aesthetics Inc. - Organizational developments
  • Exhibit 62: GC Aesthetics Inc. - Key offerings
  • Exhibit 63: Groupe SEBBIN SAS - Vendor overview
  • Exhibit 64: Groupe SEBBIN SAS - Product segments
  • Exhibit 65: Groupe SEBBIN SAS - Key offerings
  • Exhibit 66: Ideal Implant Inc. - Vendor overview
  • Exhibit 67: Ideal Implant Inc. - Key offerings
  • Exhibit 68: Johnson & Johnson - Vendor overview
  • Exhibit 69: Johnson & Johnson - Business segments
  • Exhibit 70: Johnson & Johnson - Organizational developments
  • Exhibit 71: Johnson & Johnson - Geographic focus
  • Exhibit 72: Johnson & Johnson - Segment focus
  • Exhibit 73: Johnson & Johnson - Key offerings
  • Exhibit 74: Laboratories Arion - Vendor overview
  • Exhibit 75: Laboratories Arion - Key offerings
  • Exhibit 76: POLYTECH Health & Aesthetics GmbH - Vendor overview
  • Exhibit 77: POLYTECH Health & Aesthetics GmbH - Product segments
  • Exhibit 78: POLYTECH Health & Aesthetics GmbH - Key offerings
  • Exhibit 79: Sientra Inc. - Vendor overview
  • Exhibit 80: Sientra Inc. - Business segments
  • Exhibit 81: Sientra Inc. - Organizational developments
  • Exhibit 82: Sientra Inc. - Geographic focus
  • Exhibit 83: Sientra Inc. - Segment focus
  • Exhibit 84: Sientra Inc. - Key offerings
  • Exhibit 85: Validation techniques employed for market sizing
  • Exhibit 86: Definition of market positioning of vendors
Back to Top
전화 문의
F A Q